Diagnostics

EyeMD EMR rebrands as Optivate, launching a unified, AI-driven platform. This move signals a new chapter for eye care practice management.

A novel inhaled RNA therapy for a specific group of cystic fibrosis patients gains EMA fast-track status, promising accelerated access to new treatment.

At ECR 2026, Subtle Medical showcases AI that boosts existing scanners, expands into CT, and promises faster, clearer diagnostics for patients.

The trans-pacific merger between US BioTek and Australia's NutriPATH creates a major new force in functional medicine, promising expanded global access.

Peli BioThermal and Polar Group partner to upgrade Brazil's pharma logistics, tackling a booming market and ensuring safer delivery of advanced medicines.

At MWC26, Huawei Cloud launched its Industry AI Foundry, a new hybrid cloud, and an AI coding agent, doubling down on AI to solve real-world problems.

As hearing loss surges globally, Amplifon launches a worldwide campaign of free tests and awareness, blending public health with strategic market leadership.

The biopharma company's strategic bid for non-dilutive funding could advance a first-in-class therapy for severe, untreated skin conditions.

A new partnership brings advanced, non-invasive Alzheimer's blood tests to community centers, aiming for mass early detection and reshaping diagnostics.

After a major turnaround, Genetix Biotherapeutics announces its first profitable quarter and plans to double production of its high-stakes gene therapies.

PenFed Foundation's latest accelerator cohort showcases veteran entrepreneurs tackling everything from national security to healthcare with military precision.

On its 13th anniversary, MOCO Connectors launched a new 8,000sqm facility in Zhongshan, scaling up custom connector production for global high-tech markets.

With 175 million lenses implanted, Alcon solidifies its market leadership. Discover the technology giving patients unprecedented freedom from glasses.

Neogen divests its pioneering genomics business for $160M to slash debt, while Zoetis bolsters its dominance in the animal health diagnostics market.

As MSA Awareness Month begins, a novel drug from Alterity Therapeutics shows significant promise in slowing the devastating and untreatable neurodegenerative disease.

As childhood nearsightedness soars, a new contact lens offers hope by not just correcting vision but actively slowing its progression in key global markets.

With $28M in funding and a star-studded advisory board, a new biotech firm aims to turn routine dental visits into a frontline defense against oral cancer.

In a radical pivot, diagnostics firm OpGen has become CapForce, an AI-powered investment bank targeting a $10B niche. Can it trade microbes for money?

The Michael J. Fox Foundation adds private equity and AI venture capital leaders to its board, signaling a strategic push to accelerate a cure for Parkinson's.

The stars join The Elizabeth Taylor AIDS Foundation to modernize laws from the '80s that criminalize HIV status, clashing with modern science.